Exchange: NYSEMkt·Updated 01:43 AM EDT
AIM logo

AIM AIM ImmunoTech

$0.2628
$0.0044
(1.70%)
Overnight
Prev Close $0.2584
Mkt Cap$7.87M
Vol340,565.00

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.
38

Bearish Sentiment

How do you feel about AIM?

Advertisement|Remove ads.